Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Current Assets (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Current Assets data on record, last reported at $32.5 million in Q2 2025.

  • For Q2 2025, Current Assets changed N/A year-over-year to $32.5 million; the TTM value through Jun 2025 reached $32.5 million, changed N/A, while the annual FY2024 figure was $59.0 million, 17.19% down from the prior year.
  • Current Assets reached $32.5 million in Q2 2025 per SNTI's latest filing, down from $59.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $143.9 million in Q2 2022 and bottomed at $827152.0 in Q1 2022.
  • Average Current Assets over 5 years is $58.1 million, with a median of $61.8 million recorded in 2021.
  • The widest YoY moves for Current Assets: up 9633.52% in 2023, down 55.88% in 2023.
  • A 5-year view of Current Assets shows it stood at $60.2 million in 2021, then skyrocketed by 70.42% to $102.6 million in 2022, then crashed by 30.59% to $71.2 million in 2023, then decreased by 17.19% to $59.0 million in 2024, then plummeted by 44.84% to $32.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $32.5 million in Q2 2025, $59.0 million in Q4 2024, and $71.2 million in Q4 2023.